Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 225

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 225
---
 beneficially owned by Stephen Cohen, Managing Member of Alta Partners. Stephen Cohen disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (36) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (37) | The reported securities are held directly by Warberg WF XII LP (“Warberg WF”) and may be deemed to be beneficially owned by Daniel Warsh, Manager of Warberg WF. Daniel Warsh disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (38) | Excludes, for beneficial ownership purposes, 30,024 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (39) | The reported securities are held directly by Warberg Special Situations Fund LP (“WSSF”) and may be deemed to be beneficially owned by Daniel Warsh, Manager of WSSF. Daniel Warsh disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (40) | Excludes, for beneficial ownership purposes, 30,024 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (41) | Excludes, for beneficial ownership purposes, (i) 566,037 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025 and (ii) 377,357 shares of common stock subscribed for in the Offering, but to be purchased by Thomas Mollick on or before December 31, 2025 pursuant to the terms of the Securities Purchase Agreement, dated as of June 2, 2025, between TuHURA and Thomas Mollick. |

| (42) | The securities reported are held directly by the Matthrew Joseph Nachtrab Revocable Trust dated December 18, 2014 (the “Nachtrab Trust”). Matthew Nachtrab, as trustee, has sole voting and |

145

| investment power and may be deemed the beneficial owner thereunder. Matthew Nachtrab disclaims beneficial ownership of these securities except to the extent of his pecuniary interests therein. |

| (43) | Excludes (i) 943,396 warrants to purchase common stock purchased in the Offering that